Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / February / Mapping the Molecular Identity of Human EVs
Omics Omics News and Research Mass Spectrometry

Mapping the Molecular Identity of Human EVs 

A multi-omics, machine-learning approach aims to improve extracellular vesicle classification, reproducibility, and clinical translation 

By Henry Thomas 02/04/2026 4 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
  • Top Thought Leaders

Share

Top Institutions in Extracellular Vesicle Biology and Molecular Proteomics

Leading institutions employ integrated multi-omics approaches including high-sensitivity mass spectrometry, proteomics, lipidomics, surfaceome profiling, and single-vesicle flow cytometry combined with machine learning for data integration to achieve high-resolution molecular profiling of EVs. These methodologies enable differentiation of EVs from abundant plasma proteins and non-EV particles, enhancing reproducibility and translational relevance.

  • #1

    Baker Heart and Diabetes Institute

    Melbourne, Victoria

    Pioneers in applying integrated multi-omics and advanced mass spectrometry to define the molecular identity of human circulating EVs, with a strong translational focus on cardiometabolic diseases and biomarker discovery.

    Key Differentiators

    • Molecular Proteomics
    • Extracellular Vesicle Biology
    • Cardiometabolic Research
  • #2

    Harvard Medical School - Brigham and Women's Hospital

    Boston, Massachusetts

    Leads in EV biomarker discovery and functional studies using cutting-edge proteomics and single-vesicle analysis, with extensive clinical cohort integration and translational research programs.

    Key Differentiators

    • Extracellular Vesicle Research
    • Mass Spectrometry Proteomics
    • Translational Medicine
  • #3

    University of Oxford - Radcliffe Department of Medicine

    Oxford, Oxfordshire

    Strong expertise in multi-omics integration and systems biology approaches to characterize EVs in human disease, with significant contributions to EV isolation and molecular profiling methodologies.

    Key Differentiators

    • Extracellular Vesicle Biology
    • Proteomics
    • Systems Biology
  • #4

    Johns Hopkins University School of Medicine

    Baltimore, Maryland

    Combines engineering and proteomics expertise to advance EV characterization technologies and explore their role in intercellular communication and disease diagnostics.

    Key Differentiators

    • Extracellular Vesicle Research
    • Mass Spectrometry
    • Biomedical Engineering
  • #5

    University of California, San Diego (UCSD) - Moores Cancer Center

    San Diego, California

    Focuses on EV molecular profiling in cancer, utilizing advanced mass spectrometry and multi-omics to identify EV-based biomarkers for early detection and therapeutic monitoring.

    Key Differentiators

    • Extracellular Vesicle Biology
    • Proteomics
    • Cancer Biomarkers

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Henry Thomas

Deputy Editor of The Analytical Scientist

More Articles by Henry Thomas

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.